Enliven Therapeutics, Inc. (ELVN)
NASDAQ:ELVN
Want to see ELVN full AI Analyst Report?
Enliven Therapeutics (ELVN) Ownership Overview
16.37% Insiders
18.24% Mutual Funds
7.51% Other Institutional Investors
9.57% ETFs
48.31% Public Companies and
Individual Investors
The ownership structure of Enliven Therapeutics (ELVN) stock is a mix of institutional, retail, and individual investors. Approximately 35.32% of the company’s stock is owned by Institutional Investors, 16.37% is owned by Insiders, and 48.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 10, 2026 | xxxxxxxxxxxxx | $295800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $35483487 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $72741245 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $11825582 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,663,349 | Insider | 12.58% | 323,776,495 | |
| 2,475,975 | Institution | 4.07% | 104,609,944 | |
| 2,281,261 | Institution | 3.75% | 96,383,277 | |
| 2,073,803 | Institution | 3.40% | 87,618,177 | |
| 2,068,511 | Institution | 3.40% | 87,394,590 | |
| 1,855,644 | Institution | 3.05% | 78,400,959 | |
| 1,643,267 | Institution | 2.70% | 69,428,031 | |
| 1,166,077 | Institution | 1.91% | 49,266,753 | |
| 1,144,262 | Institution | 1.88% | 48,345,070 | |
| 954,946 | Institution | 1.57% | 40,346,469 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,281,261 | Institution | 3.75% | 96,383,277 | |
| 2,068,511 | Institution | 3.40% | 87,394,590 | |
| 1,643,267 | Institution | 2.70% | 69,428,031 | |
| 1,166,077 | Institution | 1.91% | 49,266,753 | |
| 1,144,262 | Institution | 1.88% | 48,345,070 | |
| 712,291 | Institution | 1.17% | 30,094,295 | |
| 560,317 | Institution | 0.92% | 23,673,393 | |
| 416,922 | Institution | 0.68% | 17,614,955 | |
| 234,291 | Institution | 0.38% | 9,898,795 | |
| 226,850 | Institution | 0.37% | 9,584,413 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,617,027 | Institution | 2.66% | 63,387,458 | |
| 918,145 | Institution | 1.51% | 38,837,534 | |
| 497,648 | Institution | 0.82% | 19,507,802 | |
| 325,330 | Institution | 0.53% | 13,761,459 | |
| 319,311 | Institution | 0.52% | 13,506,855 | |
| 217,215 | Institution | 0.36% | 8,599,542 | |
| 213,415 | Institution | 0.35% | 8,449,100 | |
| 193,755 | Institution | 0.32% | 7,595,196 | |
| 175,955 | Institution | 0.29% | 6,966,058 | |
| 108,542 | Institution | 0.18% | 4,591,327 |
FAQ
Who Owns Enliven Therapeutics, Inc. (ELVN)?
According to the latest TipRanks data, approximately 7.51% of the company's stock is held by institutional investors, 16.37% is held by insiders, and 48.31% is held by retail investors.
What percentage of Enliven Therapeutics, Inc. (ELVN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.51% of Enliven Therapeutics, Inc. (ELVN) stock is held by institutional investors.
What percentage of Enliven Therapeutics, Inc. (ELVN) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.31% of Enliven Therapeutics, Inc. (ELVN) stock is held by retail investors.
Who owns the most shares of Enliven Therapeutics, Inc. (ELVN)?
Rishi Gupta owns the most shares of Enliven Therapeutics, Inc. (ELVN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.